KINTAI Biotech Outlines Industrial Extraction Processes for Loquat Leaf

KINTAI Biotech has issued a comprehensive report detailing the industrial extraction and standardization processes for loquat leaf extract, derived from Eriobotrya japonica. As global demand for plant-based bioactive compounds rises, the company aims to establish clear benchmarks for the procurement and manufacturing of these botanical ingredients.

The extract is primarily valued for its pentacyclic triterpenoid acids, specifically ursolic acid and corosolic acid. These compounds are utilized in the development of metabolic health supplements and anti-aging skincare products. KINTAI’s processing methods focus on maintaining specific concentrations of these acids, with standardized offerings currently ranging from 5% to 98% purity depending on the intended application.

The industry continues to move toward higher transparency in supply chains, emphasizing raw material traceability. By standardizing the extraction process, manufacturers aim to reduce variability in efficacy for end-market applications, such as blood sugar management and anti-inflammatory formulations.